123 related articles for article (PubMed ID: 26414447)
1. The roles of CD147 in the progression of gliomas.
Fei F; Li S; Fei Z; Chen Z
Expert Rev Anticancer Ther; 2015; 15(11):1351-9. PubMed ID: 26414447
[TBL] [Abstract][Full Text] [Related]
2. CD147/basigin promotes progression of malignant melanoma and other cancers.
Kanekura T; Chen X
J Dermatol Sci; 2010 Mar; 57(3):149-54. PubMed ID: 20060267
[TBL] [Abstract][Full Text] [Related]
3. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
Su J; Chen X; Kanekura T
Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
[TBL] [Abstract][Full Text] [Related]
4. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
5. The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma.
Yin H; Shao Y; Chen X
Neurol Sci; 2017 Jan; 38(1):129-136. PubMed ID: 27761842
[TBL] [Abstract][Full Text] [Related]
6. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.
Nabeshima K; Iwasaki H; Koga K; Hojo H; Suzumiya J; Kikuchi M
Pathol Int; 2006 Jul; 56(7):359-67. PubMed ID: 16792544
[TBL] [Abstract][Full Text] [Related]
7. CD147: regulator of hyaluronan signaling in invasiveness and chemoresistance.
Grass GD; Dai L; Qin Z; Parsons C; Toole BP
Adv Cancer Res; 2014; 123():351-73. PubMed ID: 25081536
[TBL] [Abstract][Full Text] [Related]
8. Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts.
Hatanaka M; Higashi Y; Fukushige T; Baba N; Kawai K; Hashiguchi T; Su J; Zeng W; Chen X; Kanekura T
Anticancer Res; 2014 Dec; 34(12):7091-6. PubMed ID: 25503136
[TBL] [Abstract][Full Text] [Related]
9. CD147 promotes liver fibrosis progression via VEGF-A/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells.
Yan Z; Qu K; Zhang J; Huang Q; Qu P; Xu X; Yuan P; Huang X; Shao Y; Liu C; Zhang H; Xing J
Clin Sci (Lond); 2015 Oct; 129(8):699-710. PubMed ID: 26201021
[TBL] [Abstract][Full Text] [Related]
10. Cancer-related issues of CD147.
Weidle UH; Scheuer W; Eggle D; Klostermann S; Stockinger H
Cancer Genomics Proteomics; 2010; 7(3):157-69. PubMed ID: 20551248
[TBL] [Abstract][Full Text] [Related]
11. CD147 in cardiovascular disease and thrombosis.
Pennings GJ; Kritharides L
Semin Thromb Hemost; 2014 Oct; 40(7):747-55. PubMed ID: 25280014
[TBL] [Abstract][Full Text] [Related]
12. CD147 and VEGF co-expression predicts prognosis in patients with acute myeloid leukemia.
Fu J; Fu J; Chen X; Zhang Y; Gu H; Bai Y
Jpn J Clin Oncol; 2010 Nov; 40(11):1046-52. PubMed ID: 20558462
[TBL] [Abstract][Full Text] [Related]
13. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
[TBL] [Abstract][Full Text] [Related]
14. Is CD147 a New Biomarker Reflecting Histological Malignancy of Gliomas?
Kong X; Wang Y; Dai C; Ma W; Wang R
Mol Neurobiol; 2017 Mar; 54(2):1568-1576. PubMed ID: 27206428
[TBL] [Abstract][Full Text] [Related]
15. CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1α-mediated pathway in rheumatoid arthritis.
Wang CH; Yao H; Chen LN; Jia JF; Wang L; Dai JY; Zheng ZH; Chen ZN; Zhu P
Arthritis Rheum; 2012 Jun; 64(6):1818-27. PubMed ID: 22170561
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment.
Yang H; Zou W; Chen B
Cell Biol Int; 2013 Oct; 37(10):1139-42. PubMed ID: 23686717
[TBL] [Abstract][Full Text] [Related]
17. EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.
Liu DT
Tumour Biol; 2015 Jul; 36(7):4883-8. PubMed ID: 25967458
[TBL] [Abstract][Full Text] [Related]
18. Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma.
Huang C; Sun Z; Sun Y; Chen X; Zhu X; Fan C; Liu B; Zhao Y; Zhang W
Histopathology; 2012 Apr; 60(5):793-803. PubMed ID: 22320715
[TBL] [Abstract][Full Text] [Related]
19. CD147 expression in pituitary adenomas and its significance for clinical outcome.
Qu X; Yang W; Jiang M; Han T; Han L; Qu Y; Wang G; Shi D; Xu G
Hum Pathol; 2010 Aug; 41(8):1165-71. PubMed ID: 20381119
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and invasion in glioma.
Onishi M; Ichikawa T; Kurozumi K; Date I
Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
